结直肠癌治疗的新治疗方法。
Novel Therapeutic Approaches for Colorectal Cancer Treatment.
机构信息
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Institute of Genetics and Biophysics 'Adriano Buzzati-Traverso', CNR, 80131 Naples, Italy.
出版信息
Int J Mol Sci. 2024 Feb 13;25(4):2228. doi: 10.3390/ijms25042228.
Abstract
According to GLOBOCAN 2020 data, colorectal cancer (CRC) represents the third most common malignancy and the second most deadly cancer worldwide [...].
摘要
根据 GLOBOCAN 2020 数据，结直肠癌（CRC）是全球第三大常见恶性肿瘤，也是第二大最致命的癌症。
相似文献
1
Novel Therapeutic Approaches for Colorectal Cancer Treatment.
Int J Mol Sci. 2024 Feb 13;25(4):2228. doi: 10.3390/ijms25042228.
2
Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer.
Clin Exp Metastasis. 2020 Dec;37(6):649-656. doi: 10.1007/s10585-020-10058-8. Epub 2020 Oct 24.
3
Advanced Machine Learning in Prediction of Second Primary Cancer in Colorectal Cancer.
Stud Health Technol Inform. 2020 Jun 16;270:1191-1192. doi: 10.3233/SHTI200357.
4
Sidedness of Colorectal Cancer Impacts Risk of Second Primary Gastrointestinal Malignancy.
Ann Surg Oncol. 2019 Jul;26(7):2037-2043. doi: 10.1245/s10434-019-07326-7. Epub 2019 Apr 4.
5
Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.
BMC Cancer. 2018 Mar 15;18(1):297. doi: 10.1186/s12885-018-4197-9.
6
Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications.
Cancer Lett. 2021 Apr 28;504:67-80. doi: 10.1016/j.canlet.2021.01.009. Epub 2021 Feb 10.
7
Modulating the activity of fluoropyrimidines against colorectal cancer by Vitamin D and its analogs.
Folia Med Cracov. 2022 Sep 15;62(3):51-61. doi: 10.24425/fmc.2022.142368.
8
Emerging mechanisms progress of colorectal cancer liver metastasis.
Front Endocrinol (Lausanne). 2022 Dec 8;13:1081585. doi: 10.3389/fendo.2022.1081585. eCollection 2022.
9
Cellular senescence: a promising therapeutic target in colorectal cancer.
Future Oncol. 2022 Sep;18(30):3463-3470. doi: 10.2217/fon-2021-0661. Epub 2022 Sep 7.
10
Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Int J Colorectal Dis. 2023 Mar 30;38(1):88. doi: 10.1007/s00384-023-04366-0.
引用本文的文献
1
Drug-induced second tumors: a disproportionality analysis of the FAERS database.
Discov Oncol. 2025 May 16;16(1):786. doi: 10.1007/s12672-025-02502-6.
2
Regulatory role of PPAR in colorectal cancer.
Cell Death Discov. 2025 Jan 28;11(1):28. doi: 10.1038/s41420-025-02313-2.
3
Advances in Molecular Mechanisms and Therapeutic Strategies in Colorectal Cancer: A New Era of Precision Medicine.
Int J Mol Sci. 2025 Jan 2;26(1):346. doi: 10.3390/ijms26010346.
4
Photodynamic Therapy against Colorectal Cancer Using Porphin-Loaded Arene Ruthenium Cages.
Int J Mol Sci. 2024 Oct 9;25(19):10847. doi: 10.3390/ijms251910847.
本文引用的文献
1
Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines.
BMC Cancer. 2023 Oct 12;23(1):971. doi: 10.1186/s12885-023-11410-3.
2
Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease.
Signal Transduct Target Ther. 2023 Oct 2;8(1):375. doi: 10.1038/s41392-023-01608-z.
3
Pictilisib-Induced Resistance Is Mediated through FOXO1-Dependent Activation of Receptor Tyrosine Kinases in Mucinous Colorectal Adenocarcinoma Cells.
Int J Mol Sci. 2023 Aug 2;24(15):12331. doi: 10.3390/ijms241512331.
4
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report.
Int J Mol Sci. 2023 Jul 27;24(15):12056. doi: 10.3390/ijms241512056.
5
Gene and ABCG2 Protein Expression in Colorectal Cancer-In Silico and Wet Analysis.
Int J Mol Sci. 2023 Jun 23;24(13):10539. doi: 10.3390/ijms241310539.
6
Immune-related adverse events of immune checkpoint inhibitors: a review.
Front Immunol. 2023 May 25;14:1167975. doi: 10.3389/fimmu.2023.1167975. eCollection 2023.
7
Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human Colorectal Carcinoma-An Unexpected Correlation to Guide Future Treatment?
Int J Mol Sci. 2023 May 3;24(9):8198. doi: 10.3390/ijms24098198.
8
Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody CMab-9 for Multiple Applications against Colorectal Carcinomas.
Int J Mol Sci. 2023 Feb 16;24(4):4007. doi: 10.3390/ijms24044007.
9
LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer.
J Exp Clin Cancer Res. 2022 Oct 26;41(1):315. doi: 10.1186/s13046-022-02516-w.
10
Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options.
Front Immunol. 2022 Jan 27;13:828330. doi: 10.3389/fimmu.2022.828330. eCollection 2022.
Zotero 插件